Vendor Integration: Focus on Customer and Cost Leads Manufacturers to Novel Approach
December 05, 2011
Viewpoints: The Last Word
Specialty pharmaceuticals, and the supporting patient and physician ancillary services, have emerged as a focal point for the majority of manufacturers. The increasing number of specialty drugs available in the United States, coupled with the heightened research and development focus of major pharmaceutical manufacturers on biotech therapies, has resulted in an unprecedented shift in dynamics across the prescription drug industry.